Immunohistochemistry (IHC) is an indispensable application routinely employed in academic and clinical research as well as in patient care. In addition to the quality of tissue section preparation, the pivotal component determining the reliability of IHC data is the suitability of the antibody used. This can only be assessed through strict and focused reagent validation.
With this in mind, GeneTex has introduced its HistoMAX product line that consists of antibodies specifically vetted for IHC. All of these reagents were extensively evaluated for IHC, utilising formalin-fixed normal and cancer tissue microarrays for good specificity and high performance. Only antibodies that have passed these stringent performance criteria for IHC will be added to the HistoMAX portfolio.
Phone: 02 9698 2022
Lumiprobe DusQ fluorescence quenchers
Lumiprobe offers a series of DusQ fluorescence quenchers with different spectral properties and...
Enzo Life Sciences SCREEN-WELL Epigenetics library
Enzo Life Sciences' SCREEN-WELL Epigenetics library contains 43 compounds with defined...
LSBio PathPlus Cancer Antibodies
The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer...
